financetom
Business
financetom
/
Business
/
Fedex Insider Sold Shares Worth $407,080, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fedex Insider Sold Shares Worth $407,080, According to a Recent SEC Filing
Mar 28, 2024 2:16 PM

04:51 PM EDT, 03/28/2024 (MT Newswires) -- R Brad Martin, Director, on March 28, 2024, sold 1,412 shares in Fedex ( FDX ) for $407,080. Following the Form 4 filing with the SEC, Martin has control over a total of 73,009 shares of the company, with 6,409 shares held directly and 66,600 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1048911/000112760224011380/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's WeRide prices HK listing, seeks to raise $307.7 million
China's WeRide prices HK listing, seeks to raise $307.7 million
Nov 4, 2025
Nov 4 (Reuters) - Chinese autonomous-driving firm WeRide ( WRD ) on Tuesday set the final offer price for its Hong Kong share sale at HK$27.10 per share, saying it expects to raise HK$2.39 billion ($307.69 million) from the listing. The Guangzhou-based company said it will offer about 88.3 million shares at HK$27.10 each and expects trading to begin on...
Market Chatter: Amazon.com Demands Perplexity to Stop Using AI Agent Comet for Online Purchases
Market Chatter: Amazon.com Demands Perplexity to Stop Using AI Agent Comet for Online Purchases
Nov 4, 2025
02:25 PM EST, 11/04/2025 (MT Newswires) -- Amazon.com ( AMZN ) has sent a cease-and-desist letter to Perplexity AI, demanding it to stop allowing its Comet browser agent to make online purchases for users, Bloomberg News reported Tuesday, citing unnamed people familiar with the letter. The e-commerce giant claims that the tool violates its terms of service, and harms the...
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
Nov 4, 2025
The U.S. Food and Drug Administration (FDA) on Monday provided feedback to uniQure N.V. regarding its investigational gene therapy for Huntington's disease. QURE is among today's weakest performers. Stay ahead of the curve here uniQure believes that the FDA currently disagrees that the data from the Phase 1/2 studies of AMT-130, in comparison to an external control, as per the...
-- Almadex Minerals Brief: Providing An Overview of Its Diversified Portfolio of Royalties On Precious and Base Metal Projects Throughout North America
-- Almadex Minerals Brief: Providing An Overview of Its Diversified Portfolio of Royalties On Precious and Base Metal Projects Throughout North America
Nov 4, 2025
02:27 PM EST, 11/04/2025 (MT Newswires) -- Price: 0.46, Change: -0.02, Percent Change: -4.17 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved